![Clarence L. Dellio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clarence L. Dellio
No open positions remaining
Profile
Clarence L.
Dellio served as Vice President-Manufacturing at Becton, Dickinson & Co. He then worked as Chief Operating Officer & Senior Vice President at XOMA Corp.
from 1984 to 2004.
From 2004 to 2008, he was the President & Chief Operating Officer at Neosil, Inc. In 2011 to 2013, he served as Chief Operating Officer at Aevi Genomic Medicine, Inc. Mr. Dellio obtained his undergraduate degree from Bentley University.
Former positions of Clarence L. Dellio
| Companies | Position | End |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Chief Operating Officer | 30/12/2013 |
Neosil, Inc.
 Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | - |
| XOMA ROYALTY CORPORATION | Chief Operating Officer | 31/12/2003 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Training of Clarence L. Dellio
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Neosil, Inc.
Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
- Stock Market
- Insiders
- Clarence L. Dellio
